I mostly agree, but I think there are some caveats here. If the duration of immunity is shorter than expected, or if long term health issues turn out to be fair

I mostly agree, but I think there are some caveats here. If the duration of immunity is shorter than expected, or if long term health issues turn out to be fairly significant and prevalent, then Sweden's strategy won't end up looking too good. And of course the other caveat is that when these strategies were implemented, the number of unknowns about COVID was much higher. So even if the outcome of their strategy ends up being acceptable, that still doesn't mean they made the correct decision base on the knowledge that was available at the time.